Skip to main content

Advertisement

SpringerLink
Log in

Calcineurin antagonists in vulvar lichen sclerosus

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Lichen sclerosus et atrophicus is a chronic inflammatory disorder that mainly affects girls of premenarchial age and women in their fifties. Besides the anogenital region, lichen sclerosus (LS) may also affect extragenital or mucosal areas. Symptoms include soreness and pruritus, but other less common symptoms are not rare. An increased activity of fibroblasts causes increased sclerosis of the affected skin. Latest studies have identified LS as a chronic inflammatory dermatosis. Auto-antibodies against the extracellular membrane protein-1 are present in up to 80% of the patients. Moreover, in the widely accepted therapy with potent corticosteroids promising results have been presented using calcineurin antagonists in the treatment of LS. An interdisciplinary management and a continued care of patients with LS will improve the clinical manifestations and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ridley CM, Frankman O, Jones IS et al (1989) New nomenclature for vulvar disease: International society for the study of vulvar disease. Hum Pathol 20:495–496

    Article  PubMed  CAS  Google Scholar 

  2. Powell J, Wojnarowska F (2002) Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med 47:706–709

    PubMed  Google Scholar 

  3. Kizer WS, Prarie T, Morey AF (2003) Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system. South Med J 96:9–11

    Article  PubMed  Google Scholar 

  4. Powell J, Wojnarowska F (2001) Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 44:803–806

    Article  PubMed  CAS  Google Scholar 

  5. Meyrick Thomas RH, Ridley CM et al (1988) Lichen sclerosus et atrophicus and autoimmunity—a study of 350 women. Br J Dermatol 118:41–46

    Article  PubMed  CAS  Google Scholar 

  6. Assmann T, Becker-Wegerich P, Grewe M et al (2003) Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 48:935–937

    Article  PubMed  Google Scholar 

  7. Scrimin F, Rustja S, Radillo O et al (2000) Vulvar lichen sclerosus: an immunologic study. Obstet Gynecol 95:147–150

    Article  PubMed  CAS  Google Scholar 

  8. Oyama N, Chan I, Neill SM et al (2003) Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 362:118–123

    Article  PubMed  CAS  Google Scholar 

  9. Jensen T, Worsaae N, Melgaard B (2002) Oral lichen sclerosus et atrophicus: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:702–706

    Article  PubMed  Google Scholar 

  10. Powell JJ, Wojnarowska F (1999) Lichen sclerosus. Lancet 353:1777–1783

    Article  PubMed  CAS  Google Scholar 

  11. Carlson JA, Grabowski R, Chichetser P et al (2000) Comparative immunophenmotypic stuidy of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous—implications für pathogenesis. Am J Dermatopathol 22:7–16

    Article  PubMed  CAS  Google Scholar 

  12. Oyama N, Chan I, Neill SM et al (2004) Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 113:1550–1559

    PubMed  CAS  Google Scholar 

  13. Neill SM, Ridley CM (2001) Management of anogenital lichen sclerosus. Clin Exp Dermatol 26:637–643

    Article  PubMed  CAS  Google Scholar 

  14. Cooper SM, Gao XH, Powell JJ et al (2004) Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 140:702–706

    Article  PubMed  CAS  Google Scholar 

  15. Dahlman-Ghozlan K, Hedblad MA, von Krogh G (1999) Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05% cream: a retrospective clinical and histopathological study. J Am Acad Dermatol 40:451–457

    Article  PubMed  CAS  Google Scholar 

  16. Dalziel KL, Millard PR, Wojnarowska F (1991) The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 124:461–464

    Article  PubMed  CAS  Google Scholar 

  17. Lorenz B, Kaufman RH, Kutzner SK (1998) Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 43:790–794

    PubMed  CAS  Google Scholar 

  18. Hillemanns P, Untch M, Prove F et al (1999) Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 93:71–74

    Article  PubMed  CAS  Google Scholar 

  19. Reichrath J, Reinhold U, Tilgen W (2002) Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy: an open pilot study in 12 patients. Dermatology 205:245–248

    Article  PubMed  CAS  Google Scholar 

  20. Alomar A, Berth-Jones J, Bos JD et al (2004) The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151(Suppl 70):3–27

    Article  PubMed  CAS  Google Scholar 

  21. Ruzicka T, Bieber T, Schopf E et al (1997) A short-term trial of Tacrolimus ointment for atopic dermatitis. European tacrolimus multicenter atopic dermatitis study group. N Engl J Med 337:816–821

    Article  PubMed  CAS  Google Scholar 

  22. Meykadeh N, Hengge UR (2003) Topische Immunmodulation in der Dermatologie. Hautarzt 54:641–662

    Article  PubMed  CAS  Google Scholar 

  23. Stander S, Luger TA (2003) Antipruritic effects of pimecrolimus and Tacrolimus. Hautarzt 54:413–417

    Article  PubMed  CAS  Google Scholar 

  24. Bohm M, Frieling U, Luger TA, Bonsmann G (2003) Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 139:922–924

    Article  PubMed  Google Scholar 

  25. Kunstfeld R, Kirnbauer R, Stingl G, Karlhofer FM (2003) Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 139:850–852

    Article  PubMed  Google Scholar 

  26. Goldstein AT, Marinoff SC, Christopher K (2004) Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J Pediatr Adolesc Gynecol 17:35–37

    Article  PubMed  Google Scholar 

  27. Goldstein AT, Marinoff SC, Christopher K (2004) Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. J Reprod Med 49:778–780

    PubMed  Google Scholar 

  28. Hagedorn M, Buxmeyer B, Schmitt Y, Bauknecht T (2002) Survey of genital lichen sclerosus in women and men. Arch Gynecol Obstet 266:86–91

    Article  PubMed  CAS  Google Scholar 

  29. Kanwar AJ, Thami GP, Kaur S et al (2002) Squamous cell carcinoma in long-standing untreated lichen sclerosus et atrophicus of the penis. Urol Int 68:291–294

    Article  PubMed  Google Scholar 

  30. Carli P, Cattaneo A, De Magnis A et al (1995) Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 4:491–495

    Article  PubMed  CAS  Google Scholar 

  31. Hengge UR, Ruzicka T, Cork M et al (2005) Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol (in press)

  32. von Krogh G, Dahlman-Ghozlan K, Syrjanen S (2002) Potential human papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus. J Eur Acad Dermatol Venereol 16:130–133

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Alfried-Krupp-Hospital, Alfried-Krupp-Str 61, 45131, Essen, Germany

    Hans J. Strittmatter

  2. Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany

    Ulrich R. Hengge & Sonja R. Blecken

Authors
  1. Hans J. Strittmatter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich R. Hengge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sonja R. Blecken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans J. Strittmatter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strittmatter, H.J., Hengge, U.R. & Blecken, S.R. Calcineurin antagonists in vulvar lichen sclerosus. Arch Gynecol Obstet 274, 266–270 (2006). https://doi.org/10.1007/s00404-006-0151-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-006-0151-1

Keywords

Search

Navigation